MX2019014445A - Moisturizing topical preparation. - Google Patents

Moisturizing topical preparation.

Info

Publication number
MX2019014445A
MX2019014445A MX2019014445A MX2019014445A MX2019014445A MX 2019014445 A MX2019014445 A MX 2019014445A MX 2019014445 A MX2019014445 A MX 2019014445A MX 2019014445 A MX2019014445 A MX 2019014445A MX 2019014445 A MX2019014445 A MX 2019014445A
Authority
MX
Mexico
Prior art keywords
topical preparation
moisturizing topical
moisturizing
animal
pharmaceutically acceptable
Prior art date
Application number
MX2019014445A
Other languages
Spanish (es)
Inventor
Ishikawa Kotaro
KASHIWAMURA Takuro
Kato Takuya
Koga Toru
Ishikawa Suguru
Original Assignee
Oji Holdings Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oji Holdings Corp filed Critical Oji Holdings Corp
Publication of MX2019014445A publication Critical patent/MX2019014445A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Abstract

The present invention provides a moisturizing topical preparation containing as an active ingredient at least one selected from pentosan polysulfate and pharmaceutically acceptable salts thereof as well as solvates of these pharmaceutically acceptable pentosan polysulfates as a novel moisturizing topical preparation. Because the moisturizing topical preparation of the present invention has a substance free of animal-derived components as the active ingredient, it can be produced as a moisturizing topical preparation free of animal-derived components as needed.
MX2019014445A 2017-05-31 2018-05-30 Moisturizing topical preparation. MX2019014445A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2017108001 2017-05-31
JP2017175133 2017-09-12
JP2017244051 2017-12-20
PCT/JP2018/020644 WO2018221547A1 (en) 2017-05-31 2018-05-30 Moisturizing topical preparation

Publications (1)

Publication Number Publication Date
MX2019014445A true MX2019014445A (en) 2020-02-10

Family

ID=64455406

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019014445A MX2019014445A (en) 2017-05-31 2018-05-30 Moisturizing topical preparation.

Country Status (12)

Country Link
US (1) US11278485B2 (en)
EP (1) EP3632451A4 (en)
JP (1) JP6555431B2 (en)
KR (2) KR20240023711A (en)
CN (1) CN110678189A (en)
AU (1) AU2018276567B2 (en)
BR (1) BR112019025030A2 (en)
CA (1) CA3065747A1 (en)
MX (1) MX2019014445A (en)
PH (1) PH12019502676A1 (en)
SG (2) SG11201911318SA (en)
WO (1) WO2018221547A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200051688A (en) * 2017-09-12 2020-05-13 오지 홀딩스 가부시키가이샤 Method for producing polysulfuric acid pentosan and polysulfuric acid pentosan
MX2020006605A (en) 2017-12-20 2020-09-10 Oji Holdings Corp Pentosan polysulfate and medicine containing pentosan polysulfate.
TW201940178A (en) * 2018-01-31 2019-10-16 日商瑪路弘股份有限公司 Topical dermatological composition
TW201940177A (en) * 2018-01-31 2019-10-16 日商瑪路弘股份有限公司 External composition for skin
TW201940179A (en) * 2018-01-31 2019-10-16 日商瑪路弘股份有限公司 Skin composition for external use
JPWO2022114111A1 (en) * 2020-11-27 2022-06-02

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4843100B1 (en) 1969-09-05 1973-12-17
US4168742A (en) 1978-03-27 1979-09-25 Hudson Products Corporation Tube bundle
FR2538404B1 (en) 1982-12-28 1985-08-23 Anic Spa
FR2543145B1 (en) 1983-03-24 1986-10-17 Sanofi Sa NOVEL XYLAN SULPHATES, THEIR PREPARATION PROCESS AND THEIR ANTI-THROMBOTIC AND HYPOLIPEMIC ACTIVITY
JPS60112708A (en) 1983-11-24 1985-06-19 Maruho Kk Humectant for skin
FR2572731B1 (en) 1984-11-07 1987-03-06 Sanofi Sa NOVEL LOW MOLECULAR WEIGHT XYLAN SULPHATES, PROCESS FOR THEIR PREPARATION AND ORAL ANTITHROMBOTIC AND HYDROPHOLIC ACTIVITY
JPS61130301A (en) 1984-11-30 1986-06-18 Tokyo Univ Xylofuranan sulfate having anticoagulant activity and its production
JPS61130302A (en) 1984-11-30 1986-06-18 Tokyo Univ Ribofuranan sulfate having anticoagulant activity and its production
JPS624362A (en) 1985-07-01 1987-01-10 Victor Co Of Japan Ltd Solid-state image pickup device
US5672334A (en) 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
FR2645745B1 (en) 1989-04-12 1991-09-27 Anben Ste Civile THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF SNORING
DE3917982A1 (en) 1989-06-02 1990-12-06 Behringwerke Ag USE OF XYLANPOLYHYDROGENSULFATES FOR THE THERAPY OF CELL PROBLEMATION-RELATED DISEASES
FR2648463B1 (en) 1989-06-14 1993-01-22 Inst Fs Rech Expl Mer SULPHATE POLYSACCHARIDES, ANTICOAGULATING AGENT AND ANTI-COMPLEMENTARY AGENT OBTAINED FROM BROWN ALGAE FUCANES AND PROCESS FOR OBTAINING SAME
BR9106377A (en) * 1990-04-26 1993-04-27 Cytrx Corp COMPOSITION AND PROCESS FOR TOPICAL TREATMENT OF INJURED OR NURSING TISSUE
US20010005720A1 (en) 1995-06-07 2001-06-28 U.S.A. As Represented By The Secretary Department Of Health And Human Services Method of treating chronic progressive vascular scarring diseases
DE19632840A1 (en) * 1996-08-14 1998-02-19 Landsberger Albert Composition containing vitamin A
JPH10195107A (en) * 1997-01-10 1998-07-28 Shiseido Co Ltd Sulfated oligohyaluronic acid
JP4336905B2 (en) * 1997-12-19 2009-09-30 マルホ株式会社 Skin moisturizing emulsion lotion containing sulfated polysaccharide
US6593310B1 (en) 2000-11-21 2003-07-15 Arthropharm Pty. Ltd. Treatment of osteoporosis
DE10141106A1 (en) * 2001-08-22 2003-03-13 Aventis Pharma Gmbh Use of heparinoid derivatives for the treatment and diagnosis of heparinoid-treatable diseases
JP4073661B2 (en) 2001-12-20 2008-04-09 王子製紙株式会社 Method for producing acidic xylooligosaccharide composition
JP3772749B2 (en) 2002-01-25 2006-05-10 王子製紙株式会社 Melanin production inhibitor
JP2003221339A (en) 2002-01-29 2003-08-05 Oji Paper Co Ltd Anti-inflammatory agent
ITMI20031618A1 (en) 2003-08-06 2005-02-07 Inalco Spa POLYSACCHARIDE DERIVATIVES EQUIPPED WITH HIGH ACTIVITY
PL1748781T3 (en) 2004-05-27 2013-05-31 Baxter Int Methods for treating bleeding disorders using sulfated polysaccharides
PL1778709T3 (en) 2004-08-05 2008-10-31 Ivax Drug Res Institute Ltd Polysulfated glycosides and salts thereof
US20060194759A1 (en) * 2005-02-25 2006-08-31 Eidelson Stewart G Topical compositions and methods for treating pain and inflammation
CA2616230A1 (en) 2005-07-22 2007-02-01 Trf Pharma, Inc. Method for treating sickle cell disease and sickle cell disease sequelae
HUE058709T2 (en) 2006-04-03 2022-09-28 Ceva Animal Health Pty Ltd Stabilized pentosan polysulfate (pps) formulations
GB0610350D0 (en) 2006-05-25 2006-07-05 Univ Liverpool prevention and/or treatment of neuodegenerative disorders
JPWO2008066193A1 (en) 2006-11-27 2010-03-11 チッソ株式会社 Cosmetic composition
US20100105889A1 (en) 2007-03-06 2010-04-29 Pandurang Balwant Deshpande Process for the preparation of pentosan polysulfate or salts thereof
FI121811B (en) 2007-06-01 2011-04-29 Upm Kymmene Corp New dispersions and processes for their preparation
HUP0900072A2 (en) * 2009-02-06 2010-09-28 Egis Gyogyszergyar Nyilvanosan Transdermal pharmaceutical compositions
WO2009087581A1 (en) 2008-01-04 2009-07-16 Alembic Limited An improved process for the preparation of pentosan polysulfate or salts thereof
JP2009196915A (en) 2008-02-20 2009-09-03 Ezaki Glico Co Ltd Composition for cosmetic
AU2008100730B4 (en) 2008-07-04 2008-10-02 Parnell Technologies Pty Ltd Sulfated polysaccharide compound for clinical use and the preparation thereof
FR2935386B1 (en) 2008-08-26 2010-09-10 Sanofi Aventis NOVEL POLYSACCHARIDES WITH ANTITHROMBOTIC ACTIVITY COMPRISING A COVALENT LIAISON WITH AN AMINO CHAIN
SG2014006985A (en) 2009-02-02 2014-04-28 Otsuka Pharma Co Ltd Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
CN102061323B (en) 2010-11-10 2013-09-25 山东龙力生物科技股份有限公司 Comprehensive utilization process of wood cellulose
WO2012101544A1 (en) 2011-01-29 2012-08-02 Alembic Pharmaceuticals Limited An improved process for the preparation of pentosan polysulfate or salts thereof
WO2012114349A1 (en) 2011-02-23 2012-08-30 Cadila Healthcare Limited An improved process for the preparation of pentosan polysulfate sodium
CN102766225B (en) 2011-05-06 2015-08-05 上海医药工业研究院 A kind of piperylene gathers the preparation method of sodium sulfate and a kind of oligomeric xylose
WO2013186857A1 (en) 2012-06-12 2013-12-19 株式会社リボミック Aptamer to fgf2 and use thereof
ITMI20130112A1 (en) 2013-01-24 2014-07-25 Chemi Spa QUALIFICATION METHOD OF PENTOSAN POLYPHOSPHATE PREPARATIONS, ITS RAW MATERIALS AND PRODUCTION PROCESSES
JO3529B1 (en) 2013-02-08 2020-07-05 Amgen Res Munich Gmbh Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains
JP6132302B2 (en) 2013-05-28 2017-05-24 リーディアント・バイオサイエンシーズ・ソシエタ・アノニマＬｅａｄｉａｎｔ Ｂｉｏｓｃｉｅｎｃｅｓ Ｓ．Ａ． Derivatives of partially desulfated glycosaminoglycans as heparanase inhibitors with anti-angiogenic activity and no anticoagulant effect
CN103320548A (en) 2013-06-24 2013-09-25 稼禾生物股份有限公司 Method for preparing xylooligosaccharide and cellulose by using crop straws
JP6403317B2 (en) 2013-07-19 2018-10-10 学校法人慶應義塾 Antitumor agent
US10870711B2 (en) 2015-05-20 2020-12-22 Chemi S.P.A. Process for the preparation of polysaccharides
EP3302705A4 (en) 2015-05-27 2019-01-23 Vanguard Therapeutics, Inc. Pentosan polysulfate sodium for the treatment of sickle cell disease
CN106832020A (en) 2015-12-04 2017-06-13 长春工业大学 A kind of preparation technology of maize straw Pentosan sulphate
CN105907896B (en) 2016-05-16 2019-11-12 中国科学院广州能源研究所 A method of utilizing lignocellulose raw material coproduction high concentration xylose and xylo-oligosaccharide
MX2020002288A (en) 2016-08-31 2020-07-14 Oji Holdings Corp Production method for acidic xylooligosaccharide, and acidic xylooligosaccharide.
JP6225321B1 (en) 2016-08-31 2017-11-08 王子ホールディングス株式会社 Method for producing polysulfate pentosan
JP6281659B1 (en) 2017-02-28 2018-02-21 王子ホールディングス株式会社 Polysulfate pentosan, pharmaceutical composition and anticoagulant

Also Published As

Publication number Publication date
CA3065747A1 (en) 2018-12-06
JPWO2018221547A1 (en) 2019-06-27
KR20240023711A (en) 2024-02-22
EP3632451A4 (en) 2021-03-10
BR112019025030A2 (en) 2020-06-16
WO2018221547A1 (en) 2018-12-06
US11278485B2 (en) 2022-03-22
AU2018276567B2 (en) 2021-09-16
AU2018276567A1 (en) 2019-12-19
EP3632451A1 (en) 2020-04-08
SG10201913607WA (en) 2020-03-30
JP6555431B2 (en) 2019-08-07
PH12019502676A1 (en) 2020-10-19
SG11201911318SA (en) 2020-01-30
US20200146963A1 (en) 2020-05-14
CN110678189A (en) 2020-01-10
KR20200011467A (en) 2020-02-03

Similar Documents

Publication Publication Date Title
PH12019502676A1 (en) Moisturizing topical preparation
NZ742208A (en) Topical pharmaceutical formulations for treating inflammatory-related conditions
CR20200274A (en) Fungicidal oxadiazoles
PH12019500579A1 (en) Pharmaceutical composition
MX2016016593A (en) Novel aminoalkyl benzothiazepine derivative and use thereof.
WO2015070224A3 (en) Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
PH12019502646A1 (en) Pyrazole magl inhibitors
PH12018502109A1 (en) Medicine obtained by combining fxr agonist and arb
MX2019003099A (en) Pharmaceutical composition.
MX2019009606A (en) Bis-compounds for optically active devices.
SG11201907938RA (en) Pentosan Polysulfate, Pharmaceutical Composition, And Anticoagulant
PH12020550125A1 (en) Crystalline forms of 3-substituted 1,2,4-oxadiazole
MX2020005483A (en) Ildr2 antagonists and combinations thereof.
MX2020002123A (en) Ribociclib salts and solid state forms thereof.
NZ731607A (en) Dihydropyrimidin-2- one compounds and medical use thereof
MX2020012989A (en) Therapeutic agent for fibrosis.
MX2019003097A (en) Pharmaceutical composition.
MX2020011756A (en) Pharmaceutical compound, salts thereof, formulations thereof, and methods of making and using same.
MX2019010330A (en) Formulations with improved stability.
MX2021010022A (en) Pharmaceutical composition.
MX2019008338A (en) Pharmaceutical composition containing sulglycotide or pharmaceutically acceptable salt thereof for preventing or treating dry eye.
PH12017502148A1 (en) Pharmaceutical compositions and use thereof
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
MY182634A (en) Pharmaceutical containing sodium-dependent phosphate transporter inhibitor
EA201791483A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MYCOSIS